Dissociation between ACE activity and autonomic response to ACE inhibition in patients with heart failure

American Heart Journal

Volumn 140, Issue 1, 2000, Pages 34-42

  Binkley, Philip F ^a   Nunziata, Enrico ^a   Haas, Carrie J ^b   Starling, Randall C ^b   Leier, Carl V ^a   Cody, Robert J ^c  

^a OHIO STATE UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRILAT;

ADULT; AGED; ARTICLE; AUTONOMIC INNERVATION; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY HEMODYNAMICS; DRUG EFFECT; DRUG INFUSION; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HEART RATE VARIABILITY; HUMAN; MALE; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; SYMPATHETIC TONE;

EID: 0033925205     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2000.107180     Document Type: Article

References (35)

1. Binkley PF, Haas GJ, Starling RC, et al. Sustained patients with congestive heart failure. J Am Coll Cardiol 1993;21:655-61.
2. Lumbers ER, McCloskey DI, Potter EK. Inhibition by angiotensin II of baroreceptor-evoked activity in cardiac vagal efferent nerves in the dog. J Physiol 1979;294:69-80.
3. Akselrod S, Gordon D, Ubel FA, et al. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science 1981;213:220-2.
4. Binkley PF, Nunziata E, Cody RJ. Influence of flosequinan on autonomic tone in congestive heart failure: implications for the mechanism of the positive chronotropic effect and survival influence of long-term vasodilator administration. Am Heart J 1994;128:1147-56.
5. Binkley PF, Nunziata E, Haas GJ, et al. Parasympathetic withdrawal is an integral component of autonomic imbalance in congestive heart failure: demonstration in human subjects and verification in a paced canine model of ventricular failure. J Am Coll Cardiol 1991;18:464-72.
6. Parati G, Di Rienzo M, Bertinieri G, et al. Evaluation of the baroreceptor-heart rate reflex by 24-hour intra-arterial blood pressure monitoring in humans. Hypertension 1988;12:214-9.
7. Watkins LL, Grossman P, Sherwood A. Noninvasive assessment of baroreflex control in borderline hypertension, comparison with the phenylephrine method. Hypertension 1996;28:238-43.
8. Mooser V, Nussberger J, Juillerat L, et al. Reactive hyperreninemia is a major determinant of plasma angiotensin II during ACE inhibition. J Cardiovasc Pharmacol 1990;15:276-82.
9. Juillerat L, Nussberger J, Menard J, et al. Determinats of angiotensin II generation during converting enzyme inhibition. Hypertension 1990;16:564-72.
10. Struthers AD. Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure. J Card Failure 1996;2:47-54.
11. Pitt B. "Escape" of aldosterone production in patients with left ventricular dsyfunction treated with an angiotensin converting enzyme inhibitor: implications for therapy. Cardiovasc Drugs Ther 1995;9:145-9.
12. Borghi C, Boschi S, Ambrosioni E, et al. Evidence of a partial escape of renin-angiotensin-aldosterone blockade in patients with acute myocardial infarction treated with ACE inhibitors. J Clin Pharmacol 1993;33:40-5.
13. Van den Meiracker AH, Man in 't Veld AJ, Admiraal PJJ, et al. Partial escape of angiotensin converting enzyme (ACE) inhibition during prolonged ACE inhibitor treatment: does it exist and does it affect the antihypertensive response? J Hypertens 1992;10:803-12.
14. Azizi M, Chatellier G, Guyene T, et al. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives. Circulation 1995;92:825-34.
15. Phillips MI. New evidence for brain angiotensin and for its role in hypertension. Federation Proceedings 1983;42:2667-72.
16. Bickerton RK, Buckley JP. Evidence for a central mechanism of angiotensin induced hypertension. Proc Soc Exp Biol Med 1961;106:834-6.
17. Hoechst AG. Effects of angiotensin II and ACE inhibitors on electircally stimulated noradrenaline release from superfused rat brain slices. Clin Exp Theory Practice 1984;A6:1847-51.
18. Kohlmann O Jr, Bresnahan M, Gavras H. Central and peripheral indices of sympathetic activity after blood pressure lowering with enalapril (MK-421) or hydralazine in normotensive rats. Hypertension 1984;6(2 Pt 2):11-16.
19. Cody RJ, Franklin KW, Kluger J, et al. Mechanisms governing the postural response and baroreceptor abnormalities in chronic congestive heart failure: effects of acute and long-term converting-enzyme inhibition. Circulation 1982;66:135-42.
20. Dibner-Dunlap ME, Smith ML, Kinugawa T, et al. Enalaprilat augments arterial and cardiopulmonary baroreflex control of sympathetic nerve activity in patients with heart failure. J Am Coll Cardiol 1996;27:358-64.
21. Dzau VJ. Implications of local angiotensin production in cardiovascular physiology and pharmacology. Am J Cardiol 1987;59A-65A.
22. Urata H, Healy B, Stewart RW, et al. Angiotensin II-forming pathways in normal and failing human hearts. Circ Res 1990;66:883-90.
23. Okunishi H, Miyazaki M, Toda N. Evidence for a putatively new angiotensin II-generating enzyme in the vascular wall. J Hypertens 1984;2:227-84.
24. Okunishi H, Miyazaki M, Okamura T, et al. Different distribution of two types of angiotensin-II generating enzymes in the aortic wall. Biochem Biophys Res Commun 1987;149:1186-92.
25. Ganten D, Minnich JL, Granger P, et al. Angiotensin-forming enzyme in brain tissue. Science 1971;173:64-5.
26. Fischer-Ferraro C, Nahmod VE, Goldstein DJ, et al. Angtiotensin and renin in rat and dog brain. J Exp Med 1971;133:353-61.
27. 3H-valine into immunoprecipitable angiotensin II. Neuroendocrinology 1975;97:536-642.
28. Yang HYT, Neff NH. Distribution and properties of angiotensin converting enzyme of rat brain. J Neurochem 1972;19:2243-50.
29. Sakaguchi K, Chai SY, Jackson B, et al. Blockade of angiotensin converting enzyme in circumventricular organs of the brain after oral lisinopril administration demonstrated by quantitative in vitro autoradiography. Clin Exp Pharmacol Physiol 1987;14:155-8.
30. Sakaguchi K, Chai SY, Jackson B, et al. Inhibition of tissue angiotensin converting enzyme, quantitation by autoradiography. Hypertension 1998;11:230-8.
31. 1. Regoli D, Barabe J. Pharmacology of bradykinin and related kinins. Pharmacol Rev 1980;32:1-46.
32. Schaefer S, Valente RA, Laslett U, et al. Cardiac reflex effects of intracoronary bradykinin in humans. J Invest Med 1996;44:160-7.
33. Uchilda Y, Murao S. Bradykinin-induced excitation of afferent cardiac sympathetic nerve fibers. Jpn Heart J 1974;15:84-91.
34. Staszewska-Barczak J, Ferreira SH, Vane JR. An excitatory nociceptive cardiac reflex elicited by bradykinin and potentiated by prostaglandins and myocardial ischaemia. Cardiovasc Res 1976;10:314-27.
35. Baker DG, Coleridge HM, Coleridge JCG, et al. Search for a cardiac nociceptor: stimulation by bradykinin of sympathetic afferent nerve endings in the heart of the cat. J Physiol (Lond) 1980;306:519-36.